Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Oncology ; (12): 904-908, 2007.
Artículo en Chino | WPRIM | ID: wpr-348176

RESUMEN

<p><b>OBJECTIVE</b>To investigate the inhibition of COX-2 gene expression and its effects on malignant proliferation of human lung adenocarcinoma A549 cells after interfering at different target sites in vitro.</p><p><b>METHODS</b>The 3rd, 7th and 10th exon of COX-2 were selected as the targets and three COX-2 siRNA expression vectors with human U6 promoter were constructed. Three siRNA expression vectors and two vacant vectors were transfected into A549 cells expressing COX-2 with lipofectamine, respectively. The transfected cell strains were constructed and the change of COX-2 expression levels was examined by Western blot and RT-PCR. The effects on the proliferation of A549 cells after interfering at different target sites were studied by cell growth curve and colony formation assay in vitro.</p><p><b>RESULTS</b>The three siRNAs and U6 promoter were validated by PCR, restriction endonuclease digestion, DNA sequencing and BLAST alignment, and cloned into the pEGFP vector. The cell strains transfected were named as A549-3, A549-7, A549-10, A549-p and A549-pU6, respectively. A549-p cells showed expression of GFP and A549-3, A549-7, A549-10, A549-p and A549-pU6 cells did not show at 24, 48 and 72 hours after transfection. The results of RT-PCR and Western blot showed an inhibition of COX-2 expression after interfering at three target sites (3rd, 7th and 10th exons). In contrast to A549 cells, the levels of COX-2 mRNA of A549-3, A549-7 and A549-10 cells were reduced by 10.6%, 33.4% and 61.2%, respectively. The levels of COX-2 protein of A549-3, A549-7 and A549-10 cells were reduced by 26.7%, 44.7% and 56.2%, respectively. The results of cell growth curve and colony formation assay showed a slowing down of the growth of A549-10 cells and reduction of their colony formation rate. The other two targets had no apparent effect on the growth of A549 cells.</p><p><b>CONCLUSION</b>There is a significant inhibiting effect of RNA interference on the malignant proliferation of A549 cells in vitro, and the most striking effect can be seen when the 10th exon of COX-2 is taken as the interference target.</p>


Asunto(s)
Humanos , Adenocarcinoma , Metabolismo , Patología , Línea Celular Tumoral , Proliferación Celular , Ciclooxigenasa 2 , Genética , Metabolismo , Fisiología , Exones , Vectores Genéticos , Neoplasias Pulmonares , Metabolismo , Patología , Regiones Promotoras Genéticas , Interferencia de ARN , ARN Mensajero , Metabolismo , ARN Interferente Pequeño , Genética , Transfección
2.
Chinese Journal of Epidemiology ; (12): 1042-1045, 2004.
Artículo en Chino | WPRIM | ID: wpr-232174

RESUMEN

<p><b>OBJECTIVE</b>To investigate the relationship between the gene polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer as well as to study the synergistic effects between smoking and the genes.</p><p><b>METHODS</b>A case-control study (case = 217, control = 200) was carried out to compare the frequent distribution of CYP1A1, 2E1, 2D6 and GSTM1 genotypes between the lung cancer group and the control group with a polymerase chain reaction-restriction fragment polymorphism (PCR-RFLP) method and to analyze the relationship between these genes and smoking.</p><p><b>RESULTS</b>GSTM1-null genotype frequency was 58.5% in the lung cancer group and 47.5% in the control group with significant difference (P = 0.02). The frequent distribution of CYP1A1, 2E1, 2D6 genotypes was not significantly different in the two groups (P > 0.05). Synergistic effects were found between smoking and GSTM1 but not between smoking and CYP1A1, 2E1, 2D6.</p><p><b>CONCLUSION</b>Smoking and GSTM1-null genotype seemed to be the risk factors of lung cancer. Those who carrying GSTM1-null genotype and smoking cigarettes were prone to suffer from lung cancer to become the high-risk population of the disease.</p>


Asunto(s)
Humanos , Masculino , Citocromo P-450 CYP1A1 , Genética , Citocromo P-450 CYP2D6 , Genética , Predisposición Genética a la Enfermedad , Genética , Glutatión Transferasa , Genética , Homocigoto , Neoplasias Pulmonares , Genética , Polimorfismo Genético
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA